Follow-up study for people with COVID infection in Shanghai
Part of Infections, Lungs & breathing clinical trials.
This study follows people in Shanghai who have tested positive for the COVID virus, even if they have no symptoms yet. It helps doctors understand what happens after infection and in people who later get a diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a positive test result for the COVID virus (SARS‑CoV‑2 RNA).
- You must sign an informed consent form to join.
- If you do not want to participate or cannot sign consent, you cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
This study follows adults who are in the hospital (including the emergency ward) with a confirmed COVID-19 infection. It aims to learn how COVID-19 affects people in the hospital and how different cases may differ over time.
This study looks at how people’s immune protection after COVID-19 may change over time. It aims to better understand immunity, which could help doctors plan future care and prevention.
This observational study follows how COVID-19 affects people in the UK over time. It may help researchers understand patterns of illness and health changes, without testing a new treatment.
This study looks at what factors may make COVID-19 symptoms or infection effects last after someone has recovered. It also collects certain body samples to better understand why this persistence happens.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.